Replies to post #217866 on Innovation Pharmaceuticals Inc (IPIX)

[Bruinfan4ever]

As i keep saying, The Nasdaq does not save a Bio Tech. A lot more shorts would attack IPIX being in the Nasdaq.

They need to uplist with strength. Non-dilutive funding.

[Justfactsmam]

...yes Clay totally mislabeled the pullback as a "pump and dump" (that mistaken labeling is what happens when you only look at charts and don't read the news which influences SP).

It was a typical reaction by retail to a $9MM Secondary offering (fully bought by institutions) below the closing from the day before, but above recent trading range Response was to be expected...how many secondaries cause a temporary selloff?...almost all do.

and yes...can scratch your head, they are on Nasdaq, trading at $2.10, with a $43MM MC, and $18MM now in bank, in pre-clinical stage with FDA clearance for Phase 1...on a "breakthrough" compound for cancer...and IPIX, trading at .67 with a $93MM MC, after all its successful trials...and is getting no recognition...but that will change soon.